☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
JAK1 Inhibitor
Gilead's Jyseleca (filgotinib) Receives the MHLW's Approval for Rheumatoid Arthritis in Japan
September 28, 2020
Load more...
Back to Home